PMID- 29464762 OWN - NLM STAT- MEDLINE DCOM- 20190930 LR - 20190930 IS - 1520-6777 (Electronic) IS - 0733-2467 (Linking) VI - 37 IP - 5 DP - 2018 Jun TI - KPR-2579, a novel TRPM8 antagonist, inhibits acetic acid-induced bladder afferent hyperactivity in rats. PG - 1633-1640 LID - 10.1002/nau.23532 [doi] AB - AIMS: Transient receptor potential melastatin 8 (TRPM8) is proposed to be a promising therapeutic target for hypersensitive bladder disorders. We examined the effects of KPR-2579, a novel selective TRPM8 antagonist, on body temperature and on mechanosensitive bladder single-unit afferent activities (SAAs) provoked by intravesical acetic acid (AA) instillation in rats. METHODS: Female Sprague-Dawley rats were used. Effects of cumulative intravenous (i.v.) administrations of KPR-2579 (0.03-1 mg/kg) on deep body temperature were investigated (N = 18). In separate animals, effects of bolus administration of KPR-2579 (0.03 or 0.3 mg/kg, i.v.) on bladder hyperactivity induced by intravesical instillation of 0.1% AA were investigated using cystometry (N = 57) in a conscious free-moving condition or urethane-anesthetized condition, and SAA measurements (N = 41) were performed in a urethane-anesthetized condition. RESULTS: KPR-2579 at any doses tested did not affect body temperature. In cystometry measurements, a high dose (0.3 mg/kg) of KPR-2579 counteracted the shortened intercontraction interval provoked by AA instillation. In SAA measurements, 48 single afferent fibers (n = 24 in each fiber) were isolated. AA instillations significantly increased the SAAs of C fibers, but not of Adelta fibers, in the presence of KPR-2579's vehicle and a low dose (0.03 mg/kg) of KPR-2579. Pretreatment with a high dose (0.3 mg/kg) of KPR-2579 significantly inhibited the AA-induced activation of C-fiber SAAs. CONCLUSION: The present results suggest that TRPM8 channels play a role in the AA-induced pathological activation of mechanosensitive bladder C fibers in rats. KRP-2579 may be a promising drug for hypersensitive bladder disorders. CI - (c) 2018 Wiley Periodicals, Inc. FAU - Aizawa, Naoki AU - Aizawa N AUID- ORCID: 0000-0002-4645-9293 AD - Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan. FAU - Fujimori, Yoshikazu AU - Fujimori Y AD - Discovery Research R&D, Kissei Pharmaceutical Co., Ltd., Azumino, Japan. FAU - Kobayashi, Jun-Ichi AU - Kobayashi JI AD - Discovery Research R&D, Kissei Pharmaceutical Co., Ltd., Azumino, Japan. FAU - Nakanishi, Osamu AU - Nakanishi O AD - Discovery Research R&D, Kissei Pharmaceutical Co., Ltd., Azumino, Japan. FAU - Hirasawa, Hideaki AU - Hirasawa H AD - Discovery Research R&D, Kissei Pharmaceutical Co., Ltd., Azumino, Japan. FAU - Kume, Haruki AU - Kume H AD - Department of Urology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan. FAU - Homma, Yukio AU - Homma Y AD - Department of Urology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan. FAU - Igawa, Yasuhiko AU - Igawa Y AD - Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180221 PL - United States TA - Neurourol Urodyn JT - Neurourology and urodynamics JID - 8303326 RN - 0 (TRPM Cation Channels) RN - 0 (Trpm8 protein, rat) RN - Q40Q9N063P (Acetic Acid) SB - IM MH - Acetic Acid MH - Animals MH - Female MH - Nerve Fibers, Unmyelinated/*drug effects/physiology MH - Neurons, Afferent/physiology MH - Rats MH - Rats, Sprague-Dawley MH - TRPM Cation Channels/*antagonists & inhibitors MH - Urinary Bladder, Overactive/chemically induced/*drug therapy OTO - NOTNLM OT - Sprague-Dawley rats OT - TRPM cation channels OT - acetic acid OT - afferent OT - urinary bladder diseases EDAT- 2018/02/22 06:00 MHDA- 2019/10/01 06:00 CRDT- 2018/02/22 06:00 PHST- 2017/12/27 00:00 [received] PHST- 2018/01/27 00:00 [accepted] PHST- 2018/02/22 06:00 [pubmed] PHST- 2019/10/01 06:00 [medline] PHST- 2018/02/22 06:00 [entrez] AID - 10.1002/nau.23532 [doi] PST - ppublish SO - Neurourol Urodyn. 2018 Jun;37(5):1633-1640. doi: 10.1002/nau.23532. Epub 2018 Feb 21.